Abstract: A particulate antiperspirant active material which has been surface treated with an alkanolamine is described. After surface treatment, the surface treatment agent is in intimate contact with the surface or outer layer of the substrate material, that is, the antiperspirant material may be either deposited on the surface or at least a fraction of the agent may be absorbed within the outer layer of the substrate. The resultant particulate material shows a reduced tendency to separate from a liquid carrier phase containing a polyglycol ether and a suspending agent.

Abstract: A hair spray composition comprising:(a) about 0.25% to about 6% by weight of a carboxylated polyurethane resin;(b) about 0.25% to about 6% by weight of a second hair fixative resin;(c) about 0% to about 80% by weight of an alcohol; and(d) about 15% to about 95% by weight water,wherein the carboxylated polyurethane resin has a weight average molecular weight of about 10,000 to about 80,000.

Abstract: A hair treatment composition for topical application comprising a hair treatment agent, and an amidopolyether functional silicone of general formula (I); ##STR1## wherein R1=(CH.sub.2).sub.3 --(NH--(CH.sub.2).sub.2).sub.z --NH.sub.2, and R2=(CH.sub.2).sub.3 --(NH--(CH.sub.2).sub.2).sub.z --NH--CO--CH.sub.2 --O--EO.sub.x --(CH.sub.2).sub.y --CH.sub.3wherein 1 is in the region 100-1500, m is in the region 0-10, n is in the region 2-50, x is in the region 1-40, y is in the region 0-21, and z is in the region 0-1.

Abstract: A conditioning shampoo composition for hair and/or skin comprises a stable microemulsion of a high viscosity, slightly cross-linked silicone with a particle size of <0.15 microns, in combination with a deposition polymer and a surfactant.

Abstract: Orthosomycins have been isolated from the fermentation broth of the microorganism Micromonospora Carbonacea var Africana designated SCC 2146. These compounds are antibacterial agents. Compositions and methods for treating bacterial infections are also described.

Abstract: 1.alpha.,25-Dihydroxy-24R-fluorocholecalciferol and 1.alpha.,25-dihydroxy-24S-fluorocholecalciferol, analogs of 1.alpha.,25-dihydroxy-cholecalciferol which is physiologically the most active metabolite of vitamin D.sub.3, are synthesized in a multistep process from the known substance 1.alpha.,3.beta.-dihydroxyandrost-5-en-17-one. The new analogs are characterized by the ability to increase intestinal calcium transport, increase serum calcium and phosphate concentrations and to increase the deposition of these minerals in bones. These compounds will find a ready application as substitutes for natural 1.alpha.,25-dihydroxycholecalciferol in the treatment of disease states characterized by metabolic calcium and phosphate deficiencies.